{"id":"CHEMBL1016","canonicalSmiles":"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"HTQMVQVXFRQIKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDESARTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CV-11974","Candesartan","Candesartan cilexetil related compound g","NSC-759858"],"crossReferences":{"PubChem":["144206031","170466386","50112728"],"Wikipedia":["Candesartan"],"drugbank":["DB13919"],"chEBI":["3347"]},"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0002610","EFO_0000275","EFO_0000373","EFO_0000266","EFO_0000538","MONDO_0005277","HP_0100543","EFO_0000289","EFO_0003144","EFO_0000712","EFO_0003100","EFO_0008573","EFO_0003047","EFO_0004701","EFO_0000400","HP_0001653","EFO_0000280","EFO_0000319","EFO_1001496","EFO_0000537","MONDO_0100431","EFO_0003896","MONDO_0002491","MONDO_0001134","MONDO_0100096","MONDO_0005147","MONDO_0005148","MONDO_0005475"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 25 investigational indications."}
{"id":"CHEMBL107201","canonicalSmiles":"N=C(N)SCCc1cccc(CCSC(=N)N)c1","inchiKey":"YEUSLPIIQGZHQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL107201","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111671"],"drugbank":["DB03910"]},"childChemblIds":["CHEMBL1255742","CHEMBL1527769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1084173","canonicalSmiles":"O=C(O)/C(=C/c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O","inchiKey":"KAMFDHLRBHTIMJ-AZDLLSQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VILANTEROL .ALPHA.-PHENYL CINNAMATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-642444H","GW642444H","Gw642444h","Vilanterol .alpha.-phenyl cinnamate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1106","canonicalSmiles":"NC1=NCC2c3ccccc3Cc3ccccc3N12","inchiKey":"WHWZLSFABNNENI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPINASTINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Elestat","Epinastine","Purivist","WAL-801"],"crossReferences":{"DailyMed":["epinastine%20hydrochloride"],"PubChem":["29217549","50111706","90340676"],"Wikipedia":["Epinastine"],"drugbank":["DB00751"],"chEBI":["51032"]},"childChemblIds":["CHEMBL1200491"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0005271","EFO_0007141","EFO_0005751","EFO_1001417","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1187724","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2","inchiKey":"PIPAJLPNWZMYQA-KNCRFDSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLATROPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methylatropine","Methylatropinium","Methylatropinium cation","Methylatropinium ion","N-methylatropine"],"crossReferences":{"drugbank":["DB13833"]},"childChemblIds":["CHEMBL2146143","CHEMBL516476"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1200799","canonicalSmiles":"CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1","inchiKey":"MKPLKVHSHYCHOC-AHTXBMBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAVOPROST","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Izba","Travatan","Travatan z","Travoprost"],"synonyms":["AL-6221","NSC-760366","Otx-tp","Travoprost"],"crossReferences":{"DailyMed":["travoprost"],"Wikipedia":["Travoprost"],"drugbank":["DB00287"],"chEBI":["746859"]},"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_1000906","MONDO_0001744","EFO_0004208","EFO_0000516","EFO_0003822","EFO_0004235"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1201198","canonicalSmiles":"Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12","inchiKey":"HIANJWSAHKJQTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMIROLAST","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pemirolast","Pemirox","Permirolast"],"crossReferences":{"PubChem":["50112688"],"Wikipedia":["Pemirolast"],"drugbank":["DB00885"]},"childChemblIds":["CHEMBL1201050"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 4 investigational indications."}
{"id":"CHEMBL1201642","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PROMPT BEEF","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Semilente insulin"],"synonyms":["Insulin zinc susp prompt beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201729","canonicalSmiles":"CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1.Cl","inchiKey":"DWKVCQXJYURSIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DRONEDARONE HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL184412","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Multaq"],"synonyms":["Dronedarone hcl","Dronedarone hydrochloride","SR-33598B","SR33598B"],"crossReferences":{"DailyMed":["dronedarone%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000136546","ENSG00000157388","ENSG00000151067","ENSG00000123700","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000081248","ENSG00000102001","ENSG00000144285","ENSG00000169432","ENSG00000138622","ENSG00000136531","ENSG00000153253"],"count":16},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009 and is indicated for atrial fibrillation. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229211","canonicalSmiles":"C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N21","inchiKey":"RHWKPHLQXYSBKR-BMIGLBTASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLUTEGRAVIR","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tivicay"],"synonyms":["Dolutegravir","GSK 1349572","GSK-1349572","GSK1349572","S-349572"],"crossReferences":{"DailyMed":["dolutegravir%20sodium"],"Wikipedia":["Dolutegravir"],"drugbank":["DB08930"],"chEBI":["76010"]},"childChemblIds":["CHEMBL1213165"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL1230997","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@H]2[C@@H](O)[C@@H](NC(C)=O)[C@H](O[C@@H]3[C@@H](CO)[C@@H]4OC(N(C)C)=N[C@@H]4[C@H]3O)O[C@@H]2CO)O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"MDWNFWDBQGOKNZ-XYUDZHFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOSAMIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allosamidin"],"crossReferences":{"drugbank":["DB04628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12318","canonicalSmiles":"O=P(O)(O)C(Cl)(Cl)P(=O)(O)O","inchiKey":"ACSIXWWBWUQEHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLODRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clodronate","Clodronic acid"],"crossReferences":{"PubChem":["90340757"],"Wikipedia":["Clodronic_acid"],"drugbank":["DB00720"],"chEBI":["110423"]},"childChemblIds":["CHEMBL1520188"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1234","canonicalSmiles":"CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O","inchiKey":"IDDIJAWJANBQLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFEROXAMINE MESYLATE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL556","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deferoxamine mesylate","Desferal","Desferal Mesylate","Desferrioxamine Mesylate"],"synonyms":["BA-33112","Deferoxamine mesilate","Deferoxamine mesylate","Deferoxamine methanesulfonate","Deferoxamini mesilas","Desferrioxamine mesilate","Desferrioxamine mesylate","NSC-756718"],"crossReferences":{"DailyMed":["deferoxamine%20mesylate"],"PubChem":["11112937","11533050","124882730","144204292","170464752","26747967"],"chEBI":["31460"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 2 investigational indications."}
{"id":"CHEMBL1235017","canonicalSmiles":"O=C(O)c1cc(=O)[nH]c(=O)[nH]1","inchiKey":"PXQPEWDEAKTCGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OROTIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Animal galactose factor","NSC-9791","Oropur","Orotic acid","Orotyl","Whey factor"],"crossReferences":{"PubChem":["144204672","144208302","170465761","17388814","174006788"],"drugbank":["DB02262"],"chEBI":["16742"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1235084","canonicalSmiles":"O=C1CCCC/C=C/CCOC(=O)c2c(O)cc(O)c(Cl)c2C1","inchiKey":"YUZYDHRGGDTZLG-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235084","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08346"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235570","canonicalSmiles":"CCCCCCCCCc1cc(O)c2ccccc2[n+]1[O-]","inchiKey":"LMBFBUICIQJLPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235570","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237046","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCCC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"HMEYVGGHISAPJR-IAHYZSEUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLITETRACYCLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Syntetrin"],"synonyms":["NSC-759177","Rolitetracycline","SO 15,659","SQ 15,659","SQ-15659","Synterin"],"crossReferences":{"drugbank":["DB01301"],"chEBI":["63334"]},"childChemblIds":["CHEMBL2105868"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1237104","canonicalSmiles":"CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.Cl","inchiKey":"QMQBBUPJKANITL-MYXGOWFTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPOXYPHENE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1213351","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2014},"tradeNames":["Darvon","Dolene","Doloxene","Kesso-gesic","Prophene 65","Propoxyphene hydrochloride","Propoxyphene hydrochloride 65"],"synonyms":["Algaphan","Deprancol","Dextro propoxyphene hydrochloride","Dextropropoxiphene chloride","Dextropropoxyphene","Dextropropoxyphene hydrochloride","Femadol","Harmar","Propoxyphene hcl","Propoxyphene hydrochloride","Propoxyphene hydrochloride cii","Proxagesic"],"crossReferences":{"PubChem":["144206413"],"chEBI":["8498"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for pain. It was withdrawn in United States  in 2014 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL127071","canonicalSmiles":"Cc1ncccc1OC[C@@H]1CCCN1","inchiKey":"YRVIKLBSVVNSHF-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POZANICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-87089.0","A-870890","ABT-089","Pozanicline"],"crossReferences":{"Wikipedia":["A-84,543"],"drugbank":["DB05458"]},"childChemblIds":["CHEMBL2105650"],"linkedTargets":{"rows":["ENSG00000147434","ENSG00000160716","ENSG00000101204","ENSG00000169684"],"count":4},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0004975","EFO_0003768"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1290003","canonicalSmiles":"CN1[C@H]2CCC[C@@H]1C[C@H](NC(=O)c1nn(C)c3ccccc13)C2","inchiKey":"MFWNKCLOYSRHCJ-BTTYYORXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1290003","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00889"],"chEBI":["5537"]},"childChemblIds":["CHEMBL1900758"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1293","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)C(C)(C)CCC1","inchiKey":"OENHQHLEOONYIE-JLTXGRSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA CAROTENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betavit","Eldon","Gerard","Golden rose","Lucaratin","Lumitene","Nature's plus","Optimum","Optimun","Solatene"],"synonyms":[".beta.-carotene","All-trans-.beta.-carotene","Beta carotene","Beta, beta-carotene","Beta,beta-carotene","Beta-carotene","Betacarotene","C.I.-40800","Caroten base 35468","Carotene,beta","Ci 40800","Ci 75130","Ci food orange 5","E-160a(iii)","Food orange 5","Ins no.160a(iii)","Ins-160a(iii)","Lucarotin 30sun","NSC-62794","Provatene","Provatenol","Rovimix .beta.-carotene","Serlabo"],"crossReferences":{"PubChem":["144205110","26750098","47193664","87219208"],"Wikipedia":["Beta-Carotene"],"drugbank":["DB06755"],"chEBI":["17579"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1356","canonicalSmiles":"O=C([O-])c1ccccc1.[Na+]","inchiKey":"WXMKPNITSTVMEF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BENZOATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amzoate","Mthwsh"],"synonyms":["Antimol","E-211","E211","FEMA NO. 3025","Fuminaru","INS NO.211","INS-211","Microcare sb","Purox s","Sobenate","Sodium benzoate"],"crossReferences":{"DailyMed":["sodium%20benzoate"],"DrugCentral":["4373"],"PubChem":["144210445"],"Wikipedia":["Sodium_benzoate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 2 investigational indications."}
{"id":"CHEMBL139050","canonicalSmiles":"O=C(O)C(=O)Nc1ccccc1C(=O)O","inchiKey":"QBYNNSFEMMNINN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-(Carboxyformamido)Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(Carboxyformamido)Benzoic Acid"],"crossReferences":{"drugbank":["DB02622"],"chEBI":["44493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14053","canonicalSmiles":"O=C(O)C(Cl)(Cl)Cl","inchiKey":"YNJBWRMUSHSURL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLOROACETIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetic acid, trichloro-","NSC-215204","TCAA","Trichloroacetate","Trichloroacetic acid","Trichloroethanoic acid"],"crossReferences":{"PubChem":["144208830","144210507","17388684","17389700","47193683"],"Wikipedia":["Trichloroacetic_acid"],"chEBI":["30956"]},"childChemblIds":["CHEMBL2028283","CHEMBL3904175"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1476605","canonicalSmiles":"CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1","inchiKey":"HQVZOORKDNCGCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFOCTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clofoctol","NSC-758389","Octofene"],"crossReferences":{"PubChem":["144204942","170466615","26748728","93576782"],"drugbank":["DB13237"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1550","canonicalSmiles":"CC1=C(C/C=C(\\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O","inchiKey":"MBWXNTAXLNYFJB-NKFFZRIASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PHYTONADIONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquamephyton","Kanavit","Konakion","Konakion mm","Konakion mm paed","Mephyton","Neokay","Orakay","Phylloquinone","Phytomenadione","Phytonadione","Vitamin K 1","Vitamin k1"],"synonyms":["NSC-270681","Phylloquinone e-form","Phytomenadione","Phytonadione","Vitamin k1"],"crossReferences":{"DailyMed":["phytonadione"],"PubChem":["144205208","170464798","47193669"],"Wikipedia":["Phylloquinone"],"drugbank":["DB01022"],"chEBI":["18067"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1576","canonicalSmiles":"C#CC1(OC(N)=O)CCCCC1","inchiKey":"GXRZIMHKGDIBEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHINAMATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valmid"],"synonyms":["Ethinamate","NSC-11538"],"crossReferences":{"Wikipedia":["Ethinamate"],"drugbank":["DB01031"],"chEBI":["4884"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1614644","canonicalSmiles":"C[N+](C)([O-])CCCN1c2ccccc2CCc2ccccc21","inchiKey":"QZIQORUGXBPDSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIPRAMINOXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imipramine n-oxide","Imipramine oxide","Imipraminoxide"],"crossReferences":{"drugbank":["DB13782"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL16225","canonicalSmiles":"c1cc[nH]c1","inchiKey":"KAESVJOAVNADME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRROLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1H-Pyrrole","1h-pyrrole","Azole","Divinylenimine","FEMA NO. 3386","Imidole","NSC-62777","Pyrrole"],"crossReferences":{"Wikipedia":["Pyrrole"],"chEBI":["19203"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1628688","canonicalSmiles":"COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1","inchiKey":"FJHHZXWJVIEFGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIBOTENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ZD-4054","ZD4054","Zibotentan"],"crossReferences":{"drugbank":["DB06629"]},"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_1001951","MONDO_0008170","EFO_0003884","EFO_0001421","EFO_0000673","MONDO_0007254","EFO_0003876","EFO_0003060","MONDO_0008315","EFO_0004265","EFO_0000311","EFO_0009708"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL1672627","canonicalSmiles":"O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1","inchiKey":"XUYURJQIMYCWBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAS101057","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Las101057"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1690","canonicalSmiles":"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O","inchiKey":"JCBIVZZPXRZKTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYCHLOROQUINE SULFATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1535","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ercoquin","Hydroxychloroquine sulfate","Oxichlorochine","Plaquenil","Quensyl","Quinoric"],"synonyms":["Ercoquin","Hydroxychloroquine Sulfate","Hydroxychloroquine sulfate","Hydroxychloroquine sulphate","NSC-4375","Oxichlorochine sulfate","Oxiklorin","Quensyl","TCMDC-123987"],"crossReferences":{"DailyMed":["hydroxychloroquine%20sulfate"],"PubChem":["144205260","170464696","26748879"]},"linkedTargets":{"rows":["ENSG00000196664","ENSG00000239732"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0002689","EFO_0000685","EFO_0001645","EFO_0004194","EFO_0003818","EFO_0001073","EFO_0005755","EFO_0005221","EFO_0003834","EFO_1000044","MONDO_0100096","EFO_0002690","EFO_0001068","EFO_0000389","EFO_0004244","EFO_0007224","Orphanet_88917","EFO_0000699"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for malaria and rheumatoid arthritis and has 12 investigational indications."}
{"id":"CHEMBL1692","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl","inchiKey":"XZZXIYZZBJDEEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IMIPRAMINE HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL11","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imipramine hydrochloride","Janimine","Pramine","Praminil","Presamine","Sarimp","Tofranil"],"synonyms":["G-22355","Imidobenzyle","Imipramine HCl","Imipramine hcl","Imipramine hydrochloride","Imipramine hydrochloride rs","Imipramini hydrochloridum","Imizine","NSC-114900","Pryleugan"],"crossReferences":{"DailyMed":["imipramine%20hydrochloride"],"PubChem":["144211734","26747552","26747553","26751601","50106516","50106517","50106518","56422890","855555"],"chEBI":["5882"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0000519"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL17860","canonicalSmiles":"CC(Oc1c(Cl)cccc1Cl)C1=NCCN1","inchiKey":"KSMAGQUYOIHWFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFEXIDINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lofexidine"],"crossReferences":{"DailyMed":["lofexidine%20hydrochloride"],"PubChem":["170466275"],"Wikipedia":["Lofexidine"],"drugbank":["DB04948"],"chEBI":["51368"]},"childChemblIds":["CHEMBL1788132"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0007191","HP_0001399","EFO_0004240","EFO_0003890","EFO_0002610","EFO_0005800","EFO_0005611","EFO_0010702"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for substance withdrawal syndrome and drug dependence and has 5 investigational indications."}
{"id":"CHEMBL1887891","canonicalSmiles":"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1.Cl","inchiKey":"ZXKXJHAOUFHNAS-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXFENFLURAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL248702","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," European Union"," Canada"," Malasia"," India"," Saudi Arabia"],"classes":["Cardiotoxicity"],"year":1997},"tradeNames":["Adifax","Redux"],"synonyms":["Adipomin","D-fenfluramine hydrochloride","Dexfenfluramine hcl","Dexfenfluramine hydrochloride","Glypolix","Isomeride","S 5614 HCL","S-5614 HCL"],"crossReferences":{"PubChem":["144206417","170465626","85273812"],"chEBI":["59730"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom,  United States,  European Union,  Canada,  Malasia,  India and  Saudi Arabia initially in 1997 due to Cardiotoxicity."}
{"id":"CHEMBL189171","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1","inchiKey":"FSQKKOOTNAMONP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEMETACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emflex"],"synonyms":["Acemetacin","NSC-757413","Rantudil"],"crossReferences":{"PubChem":["11112782","124882621","144207022","170466043","174007220","26746953","855677"],"Wikipedia":["Acemetacin"],"drugbank":["DB13783"],"chEBI":["31162"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL1907001","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1","inchiKey":"CYDRXTMLKJDRQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZODODECINIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzododecinium","Benzododecinium cation","Benzododecinium ion"],"crossReferences":{"drugbank":["DB13282"]},"childChemblIds":["CHEMBL2355417","CHEMBL1885899"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1921904","canonicalSmiles":"C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccc(F)cc3)CCC1CC2)(c1ccccc1)N1CCCCC1","inchiKey":"FNYFFCOCVNTJCD-NNMXADRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-9164","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD9164","Azd 9164","Azd-9164","Azd9164","J3.232.015E"],"crossReferences":{"drugbank":["DB12115"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL200102","canonicalSmiles":"CC(C)NCCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21","inchiKey":"SUPVGFZUWFMATN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PU-H71","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PU-H 71","PU-H-71","PU-H71","PUH-71","Pu-h71","Zelavespib"],"crossReferences":{"drugbank":["DB12638"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2057301","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AURFZBICLPNKBZ-FZCSVUEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEPRANOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allopregnan-3.beta.-ol-20-one","Epiallopregnanolone","Isoallopregnanolone","Isopregnanolone","NSC-97078","Sepranolone","U-0949","UC-1010","UC1010","Uc1010"],"crossReferences":{"drugbank":["DB12972"],"chEBI":["11909"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2062163","canonicalSmiles":"C[C@H]1[C@H](c2ccccc2)OCCN1C.O=C(O)C(O)C(O)C(=O)O","inchiKey":"VEPOHXYIFQMVHW-XOZOLZJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENDIMETRAZINE TARTRATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1615439","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adphen","Alphazine","Bontril","Bontril pdm","Cam-metrazine","Di-metrex","Melfiat","Melfiat-105","Metra","Phenazine","Phenazine-35","Phendimetrazine tartrate","Plegine","Sprx-105","Sprx-3","Statobex","Statobex-g","X-trozine","X-trozine l.a."],"synonyms":["Adipost","Appecon","Azophenylene","NSC-13157","Phendimetrazine bitartrate","Phendimetrazine tartrate","Phendimetrazine tartrate ciii"],"crossReferences":{"DailyMed":["phendimetrazine%20tartrate"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and is indicated for obesity."}
{"id":"CHEMBL2103828","canonicalSmiles":"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F","inchiKey":"LGSDFTPAICUONK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELINOGREL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elinogrel","PRT 060128","PRT-060128","Prt060128"],"crossReferences":{"drugbank":["DB06350"]},"childChemblIds":["CHEMBL2105641"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000612"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103876","canonicalSmiles":"Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1","inchiKey":"VJGFOYBQOIPQFY-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAPRACORAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BOL-303242-X","BOL-303242X","Mapracorat","ZK 245186","ZK-245186","Zk-245186"],"crossReferences":{"drugbank":["DB12041"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0003966","EFO_1000906","MONDO_0005129","EFO_0000676","EFO_0007141","EFO_0000274"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2103878","canonicalSmiles":"NC(=O)c1ccc(Oc2ccc(CNCCC3CCOCC3)cc2F)nc1","inchiKey":"QWNDOCKIKKQJNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODELEPRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2196044","LY2196044","Ly2196044","Odelepran","Ondelopran"],"crossReferences":{"drugbank":["DB12585"]},"childChemblIds":["CHEMBL2105746"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["MONDO_0007079"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104969","canonicalSmiles":"O=C(O)c1ccc(CCCc2c(CCNS(=O)(=O)Cc3ccccc3C(F)(F)F)n(C(c3ccccc3)c3ccccc3)c3ccc(Cl)cc23)cc1","inchiKey":"NHHBNHIPCSPSHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIRIPLADIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Giripladib","PLA-695"],"crossReferences":{"drugbank":["DB15426"]},"linkedTargets":{"rows":["ENSG00000116711"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0005178"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105019","canonicalSmiles":"CC(C)(C)c1ccc(CCC(O)COc2ccc(C(=O)O)cc2)cc1","inchiKey":"LNXBEIZREVRNTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFIBROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K 12148","K-12148","Lifibrol"],"crossReferences":{"drugbank":["DB12448"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2105671","canonicalSmiles":"O=C(O)C(O)C(O)C(=O)O.OC[C@H]1CNC[C@@H](O)[C@@H]1O","inchiKey":"ULBPPCHRAVUQMC-RWOHWRPJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFEGOSTAT TARTRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL206468","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-2101","AT2101","Afegostat tartrate","HGT-3410","Isofagomine tartrate","Plicera"],"linkedTargets":{"rows":["ENSG00000177628"],"count":1},"linkedDiseases":{"rows":["Orphanet_355"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106217","canonicalSmiles":"CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl","inchiKey":"ZXKXJHAOUFHNAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENFLURAMINE HYDROCHLORIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL87493","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"]},"tradeNames":["Fintepla","Ponderax","Ponderax pacaps","Pondimin"],"synonyms":["AHR-3002","Dl-fenfluramine hydrochloride","Fenfluramine hcl","Fenfluramine hydrochloride","Ganal","HHR-965"],"crossReferences":{"DailyMed":["fenfluramine%20hydrochloride"],"chEBI":["59729"]},"linkedTargets":{"rows":["ENSG00000179546","ENSG00000147955","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["Orphanet_33069","MONDO_0015643","HP_0001250"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for seizure and dravet syndrome and has 1 investigational indication. It was withdrawn in United States due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106406","canonicalSmiles":"Cc1nc2ccccc2n1CC1CCN(C(=O)/C=C(/c2ccccc2)c2ccc(/N=N/c3ccc(O)c(C(=O)O)c3)cc2)CC1","inchiKey":"RIRCDXXMYTZTPE-SDYUWQRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERSALAZINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dersalazine","UR-12746"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107433","canonicalSmiles":"c1cncc(C2=NOCC(CN3CCCCC3)N2)c1","inchiKey":"QWVRTSZDKPRPDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IROXANADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iroxanadine","Iroxanadine, (-)-"],"crossReferences":{"drugbank":["DB05444"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107792","canonicalSmiles":"CCN(CC)CCOC(=O)[C@H](Cc1ccc(NC(=O)c2c(Cl)cccc2Cl)cc1)NC(=O)c1c(C)cccc1Cl","inchiKey":"VZVNFRFMDNFPOM-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALATEGRAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-411 FREE BASE","R411 FREE BASE","RO-0272441","RO0272441","Valategrast"],"childChemblIds":["CHEMBL2107382"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108208","drugType":"Protein","blackBoxWarning":false,"name":"LENERCEPT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lenercept","RO 45-2081","RO-45-2081","Ro-452081"],"description":"Protein drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108727","drugType":"Gene","blackBoxWarning":false,"name":"TALIMOGENE LAHERPAREPVEC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oncovex-ae"],"synonyms":["JS-1 34.5-HGMCSF","JS1 34.5-HGMCSF 47- PA-","Oncovex","Oncovexgm-csf","Talimogene laherparepvec","Talmimogene laherparepvec"],"crossReferences":{"DrugCentral":["5180"]},"description":"Gene drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 13 investigational indications."}
{"id":"CHEMBL2108878","drugType":"Unknown","blackBoxWarning":false,"name":"THYROID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nature"],"synonyms":["Dessicated thyroid","Dried thyroid","NSC-26492","Thyroid","Thyroid gland","Thyroid gland preparations","Thyroid powder","Thyroid, unspecified","Thyroidinum"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109293","drugType":"Antibody","blackBoxWarning":false,"name":"KRN-330","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KRN-330","Krn 330","Krn-330","Krn330"],"linkedTargets":{"rows":["ENSG00000143167"],"count":1},"linkedDiseases":{"rows":["EFO_1001951"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109343","drugType":"Antibody","blackBoxWarning":false,"name":"LERONLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leronlimab","PRO 140","PRO-140","PRO140","Pro-140"],"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000616","EFO_0003869","MONDO_0100096","EFO_0000764","EFO_0000180","EFO_1001249"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109411","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7444","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7444"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109466","drugType":"Antibody","blackBoxWarning":false,"name":"TNX-650","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TNX-650"],"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0000183"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110895","canonicalSmiles":"CCN(CC)CCOC(=O)c1cccc(-c2ccccc2)c1O","inchiKey":"HLDCSYXMVXILQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPHENAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xenysalate"],"crossReferences":{"drugbank":["DB13815"]},"childChemblIds":["CHEMBL2106552"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110987","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@H](OC)[C@@H]1OC","inchiKey":"FPGCYQVKNKEGRQ-SXLQGMKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOSERPATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metoserpate","Pacitran"],"crossReferences":{"drugbank":["DB11530"]},"childChemblIds":["CHEMBL2106943"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL211456","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccccc1","inchiKey":"KWGRBVOPPLSCSI-WPRPVWTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPHEDRINE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-ephedrine","Ephedrine","Ephedrine, anhydrous","Ephedrinum, anhydrous","L-ephedrine","NSC-170951","NSC-8971","Xenadrine"],"crossReferences":{"DailyMed":["ephedrine%20sulfate"],"PubChem":["124892369"],"Wikipedia":["Ephedrine"],"drugbank":["DB01364"],"chEBI":["15407"]},"childChemblIds":["CHEMBL2146102","CHEMBL1523964","CHEMBL526872"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["HP_0001662","EFO_0004210","EFO_0000319","HP_0001742","EFO_0003843","EFO_0001073","EFO_0007214","EFO_0002950","MP_0001914","HP_0100543","EFO_0005758","EFO_0003144","MONDO_0004979","EFO_0009314","EFO_0003833","EFO_0000668","EFO_0003956","EFO_0005251"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 7 approved and 6 investigational indications."}
{"id":"CHEMBL218227","canonicalSmiles":"O=C(/C=C(\\O)c1nc[nH]n1)c1ccc(Cc2ccc(F)cc2)o1","inchiKey":"HFHDGHOGHWXXDT-ZSOIEALJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-1360","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-S-1360","GW-810781","GW810781","Gw810781","S 1360","S-1360"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL223147","canonicalSmiles":"CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4","inchiKey":"AOMMPEGZDRAGRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223147","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07266"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227072","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCCCNC(=O)c1cc(C)ccc1OCC[18F])CC2","inchiKey":"QVRVXSZKCXFBTE-KPVNRNJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227072","maximumClinicalTrialPhase":0,"parentId":"CHEMBL226539","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14900"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227937","canonicalSmiles":"N=C(NCCC[C@H](N)CNCCN)N[N+](=O)[O-]","inchiKey":"RMSWBHUVFNFNIZ-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227937","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217478"],"drugbank":["DB02027"]},"childChemblIds":["CHEMBL481033"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228792","canonicalSmiles":"c1coc(CNc2ncnc3[nH]cnc23)c1","inchiKey":"QANMHLXAZMSUEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KINETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kinetin"],"crossReferences":{"PubChem":["11112392","124882318","144211531","26753705","7969961"],"drugbank":["DB11336"],"chEBI":["27407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228814","canonicalSmiles":"Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1","inchiKey":"QJZRFPJCWMNVAV-HHHXNRCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISPINESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ispinesib"],"crossReferences":{"drugbank":["DB06188"]},"childChemblIds":["CHEMBL2347651"],"linkedTargets":{"rows":["ENSG00000138160"],"count":1},"linkedDiseases":{"rows":["MONDO_0002691","EFO_0003869","EFO_0000389","MONDO_0008170","EFO_0000681","EFO_1000657","EFO_0000673","MONDO_0021063","EFO_0003060","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2364637","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1.CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1.O=C(O)/C=C/C(=O)O","inchiKey":"SVUJNSGGPUCLQZ-FQQAACOVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENOFOVIR ALAFENAMIDE FUMARATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2107825","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vemlidy"],"synonyms":["GS-7340 HEMIFUMARATE","GS-7340-03","Tenofovir alafenamide fumarate","Vemlidy"],"crossReferences":{"DailyMed":["tenofovir%20alafenamide%20fumarate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL239800","canonicalSmiles":"CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1","inchiKey":"DWPQODZAOSWNHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOBAM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenobam","MCN-3377-98"],"crossReferences":{"PubChem":["144206177","144207065","170466272","174006275","26753296","90341711"],"Wikipedia":["Fenobam"],"drugbank":["DB12931"]},"childChemblIds":["CHEMBL2103779"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL252518","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4","inchiKey":"BJDCWCLMFKKGEE-CMDXXVQNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTENIMOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".beta.-dihydroartemisinin","Alaxin","Artemether related compound a","Artenimol","Artenimolum","Cotecxin","Cotexin","Di-hydroqinghaosu","Dihydroartemisinin","Dihydroartemisinin, .beta.-","Dihydroartemisinine","Dihydroqinghaosu","Dynamax","GNF-PF-5634","Salaxin","Santecxin"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for malaria and has 5 investigational indications."}
{"id":"CHEMBL271068","canonicalSmiles":"Cc1cc(NC(=O)C(=O)c2cc(Cc3ccc(C#N)cc3)n3ccccc23)sn1","inchiKey":"IZZYUABKZYIINT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSABULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rosabulin","STA-5312"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL293700","canonicalSmiles":"O=[N+]([O-])c1ccc2c(c1)CN[C@@H](CO)C2","inchiKey":"RNUCRXHRBPLYTA-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL293700","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07906"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039583","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O","inchiKey":"VMZMNAABQBOLAK-IXZCVAHUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PASIREOTIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Signifor"],"synonyms":["Pasireotide","SOM 230","SOM-230","SOM230"],"crossReferences":{"DailyMed":["pasireotide%20diaspartate"]},"childChemblIds":["CHEMBL3039588","CHEMBL3545188"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":4},"linkedDiseases":{"rows":["EFO_0003086","EFO_1001901","MONDO_0007254","EFO_0001071","EFO_1001110","EFO_0003099","EFO_0003860","EFO_0000182","EFO_1000067","EFO_0000673","MONDO_0015277","Orphanet_2495","EFO_0002618","EFO_1001307","EFO_1000616","EFO_0007331","EFO_1001256","MONDO_0002108","MONDO_0024503","EFO_0001642","EFO_0005323","EFO_0000232","EFO_0004243","EFO_0003843","MONDO_0008315","EFO_0000311","EFO_1001471","EFO_1000581","EFO_1001485","EFO_0008549","HP_0003074","EFO_0000702","EFO_0000432","EFO_0001378","HP_0001943","EFO_0008516"],"count":36},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for acromegaly and has 31 investigational indications."}
{"id":"CHEMBL3084525","canonicalSmiles":"N#Cc1ccc(N2[C@H]3CC[C@@H]2C[C@H](O)C3)c2ccccc12","inchiKey":"ATKWLNSCJYLXPF-FICVDOATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3084525","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13935"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184679","canonicalSmiles":"COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1","inchiKey":"VRQMAABPASPXMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-4547","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4547","Azd 4547","Azd-4547","Azd4547","KB-74810"],"crossReferences":{"PubChem":["174006594"]},"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["MONDO_0001056","MONDO_0007254","EFO_0000326","EFO_0008528","MONDO_0003219","EFO_0001378","EFO_0000708","EFO_0000707","EFO_0000228","EFO_0003060","EFO_0000311","MONDO_0001187"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL319111","canonicalSmiles":"O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1","inchiKey":"YEJCDKJIEMIWRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINOPIRDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DUP 996","DUP-996","Linopirdine"],"crossReferences":{"PubChem":["11111362","11114259","124880516","144203728","170466342","174006298","46500471","50104972","85231103","90341523"],"Wikipedia":["Linopirdine"],"drugbank":["DB13806"],"chEBI":["34823"]},"childChemblIds":["CHEMBL1612640"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3260771","canonicalSmiles":"COc1ccc(-c2ccc(OCc3cc(C(=O)[N-]S(=O)(=O)c4ccccc4C)oc3C)cc2)nc1.[Na+]","inchiKey":"TVDHMDXPKGMXRT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BGC-20-1531","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1628698","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP-1531","BGC 20-1531","BGC20-1531","Bgc-20-1531","Bgc20-1531","PGN 1531"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3261331","canonicalSmiles":"CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O","inchiKey":"FDBYIYFVSAHJLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESMETIROM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGL-3196","Mgl-3196","Resmetirom","VIA-3196"],"crossReferences":{"drugbank":["DB12914"]},"linkedTargets":{"rows":["ENSG00000151090"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","EFO_1001249","EFO_0004911"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3287379","canonicalSmiles":"O=C1C=CN(c2c(F)cc(N3C[C@H](CNc4ccon4)OC3=O)c(F)c2F)CC1","inchiKey":"SULYVXZZUMRQAX-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONTEZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Contezolid","MRX-1","MRX-I","Mrx-i"],"crossReferences":{"drugbank":["DB12796"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301597","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC CITRATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3991241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Auryxia"],"synonyms":["Ferric citrate","JTT-751","KRX-0502","NSC-112227"],"crossReferences":{"DailyMed":["ferric%20citrate"],"DrugCentral":["4538"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved indications."}
{"id":"CHEMBL3301609","canonicalSmiles":"Cc1cc(C)c2nc(-c3cnc(NCCCC4CCN(C)CC4)nc3C)[nH]c2c1","inchiKey":"FCRFVPZAXGJLPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOREFORANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-38518168","Jnj-38518168","Toreforant"],"crossReferences":{"drugbank":["DB12522"]},"childChemblIds":["CHEMBL3301614"],"linkedTargets":{"rows":["ENSG00000134489"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0001421","EFO_0000676","MONDO_0004979"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3400972","canonicalSmiles":"N[C@@H](Cc1cc(O)c(O)cc1[18F])C(=O)O","inchiKey":"PAXWQORCRCBOCU-RPDRGXCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORODOPA F 18","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3547132","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluorodopa f18"],"synonyms":["18f","18f-dopa","18f-l-fluoro-dopa","Fdopa f-18","Fluorodopa (18f)","Fluorodopa f 18","Fluorodopa f-18","L-6-(18f)fluoro-dopa"],"crossReferences":{"DailyMed":["fluorodopa%20f-18"],"drugbank":["DB13848"],"chEBI":["49166"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 investigational indications."}
{"id":"CHEMBL345237","canonicalSmiles":"O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1","inchiKey":"URMTUEWUIGOJBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLOZOTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piclozotan","SUN-N-4057","Sun-n4057"],"crossReferences":{"drugbank":["DB12361"]},"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180","EFO_0000712"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL348475","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2","inchiKey":"LGGHDPFKSSRQNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARIQUIDAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tariquidar","XR-9576","XR9576"],"crossReferences":{"PubChem":["174006280"],"Wikipedia":["Tariquidar"],"drugbank":["DB06240"]},"childChemblIds":["CHEMBL1214643"],"linkedTargets":{"rows":["ENSG00000085563"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","MONDO_0008903","MONDO_0008170","MONDO_0007254","EFO_1000796","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545196","canonicalSmiles":"CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.Cl.Cl","inchiKey":"NADLBPWBFGTESN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0166285","maximumClinicalTrialPhase":1,"parentId":"CHEMBL49120","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pd-0166285"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545212","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-337","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 337","Amg-337"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003897","EFO_0008498","EFO_0000478","MONDO_0003219","EFO_0000504","EFO_0000402","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545222","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD8683","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd8683"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545233","canonicalSmiles":"CC[C@H](NC(=O)c1c(NS(C)(=O)=O)c(-c2ccccc2)nc2ccccc12)c1ccccc1","inchiKey":"QYTBBBAHNIWFOD-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAVINETANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-12472520","AZ12472520","AZ124752520","AZ4901","AZD-4901","AZD2624","AZD4901","Azd 2624","Azd 4901","Azd-2624","Azd2624","MLE-4901","MLE4901","Pavinetant"],"crossReferences":{"drugbank":["DB11692"]},"linkedTargets":{"rows":["ENSG00000169836"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000660","HP_0031284"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545320","drugType":"Small molecule","blackBoxWarning":false,"name":"ME-344","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Me 344","Me-344"],"linkedTargets":{"rows":["ENSG00000178127","ENSG00000186010","ENSG00000137806","ENSG00000267855","ENSG00000119421","ENSG00000166136","ENSG00000198695","ENSG00000198840","ENSG00000158864","ENSG00000184983","ENSG00000168653","ENSG00000184752","ENSG00000099795","ENSG00000164258","ENSG00000065518","ENSG00000151366","ENSG00000170906","ENSG00000147684","ENSG00000109390","ENSG00000131495","ENSG00000004779","ENSG00000165264","ENSG00000198886","ENSG00000145494","ENSG00000125356","ENSG00000128609","ENSG00000090266","ENSG00000123545","ENSG00000119013","ENSG00000198763","ENSG00000174886","ENSG00000140990","ENSG00000213619","ENSG00000189043","ENSG00000178057","ENSG00000160194","ENSG00000164182","ENSG00000136521","ENSG00000167792","ENSG00000115286","ENSG00000139180","ENSG00000023228","ENSG00000185633","ENSG00000183648","ENSG00000130414","ENSG00000110717","ENSG00000147123","ENSG00000212907","ENSG00000198786","ENSG00000198888"],"count":50},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000305"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL360410","canonicalSmiles":"Oc1ccc(-c2noc3cc(O)ccc23)c(O)c1","inchiKey":"NBTXJDAHLMMIGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06937"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707245","canonicalSmiles":"O=C(O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1","inchiKey":"YHGSTSNEOJUIRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIDENEPAG","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omidenepag","UR-7276"],"linkedTargets":{"rows":["ENSG00000125384"],"count":1},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707280","drugType":"Antibody","blackBoxWarning":false,"name":"CG250 111IN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG250","Cg250 (111in)","Cg250 111in"],"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707384","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)O.O=C(O)C1CSC(C(=O)O)N1","inchiKey":"LUCWYYXUZVULSK-WCCKRBBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIDIACIC ARGININE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2064047","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiadilon","Tidiacic arginine"],"crossReferences":{"DrugCentral":["4735"],"drugbank":["DB13748"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3951811","canonicalSmiles":"CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl","inchiKey":"BCSHRERPHLTPEE-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3951811","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13060"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3969876","canonicalSmiles":"COCCCCn1c(C(=O)N(CC(C)C)[C@@H]2CNC[C@H](C(=O)N3CCOCC3)C2)nc2ccccc21.Cl","inchiKey":"PUXOYQIZZIWCHH-NSLUPJTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMARIKIREN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3990145","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imarikiren hydrochloride","TAK-272","Tak-272"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989977","drugType":"Antibody","blackBoxWarning":false,"name":"EMAPALUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gamifant"],"synonyms":["Emapalumab","Emapalumab-lzsg","NI-0501"],"crossReferences":{"DailyMed":["emapalumab-lzsg"]},"linkedTargets":{"rows":["ENSG00000111537"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0000540","EFO_0004599","Orphanet_158038"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for immune system disease and primary hemophagocytic lymphohistiocytosis and has 2 investigational indications."}
{"id":"CHEMBL3989989","drugType":"Gene","blackBoxWarning":false,"name":"AXICABTAGENE CILOLEUCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axicabtagene ciloleucel","KTE-C19","Yescarta"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0044889","EFO_0000096","EFO_0001642","EFO_0011057","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_1001469"],"count":9},"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3990030","drugType":"Unknown","blackBoxWarning":false,"name":"EFIZONERIMOD ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efizonerimod","Efizonerimod alfa","MEDI-6383","MEDI6383","Medi 6383"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4090674","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O","inchiKey":"XUNKPNYCNUKOAU-VXJRNSOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4090674","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12648"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297896","drugType":"Unknown","blackBoxWarning":false,"name":"ATU-027","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATU027","Atu-027","Atu027"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297961","drugType":"Unknown","blackBoxWarning":false,"name":"GMA-161","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMA-161","GMA161","Gma-161","Gma161","HUMANIZED, AGLYCOSYL ANTIBODY, GMA161"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297969","drugType":"Antibody","blackBoxWarning":false,"name":"FELADILIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3359609","Feladilimab","GSK-3359609","GSK-609","GSK3359609","Gsk 3359609","Gsk-3359609","Gsk3359609"],"linkedTargets":{"rows":["ENSG00000163600"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005950","EFO_0001378"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297971","drugType":"Protein","blackBoxWarning":false,"name":"PEPTIDE YY HUMAN (3-36)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gt-001","Human peptide yy (3-36)","Peptide yy (3-36)","Peptide yy human (3-36)","Pyy 3-36","Pyy(3-36)","Pyy3-36"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4300558","canonicalSmiles":"CN(C)C(=O)N1C[C@H]2C[C@](C)(NCC(=O)N3C[C@@H](F)C[C@H]3C#N)C[C@H]2C1","inchiKey":"WWRKIQZKFGMESZ-SFUJAXRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BESIGLIPTIN TOSYLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297430"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL438945","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC","inchiKey":"XKWCTHKJQNUFOQ-HRPSIEBRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"HUMAN NEUROPEPTIDE Y","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human neuropeptide y"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL439338","canonicalSmiles":"CC(C)(C)c1nc(N2CCN(CCCSc3nccc(O)n3)CC2)cc(C(F)(F)F)n1","inchiKey":"KXVAICSRMHXLJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-925","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-437203","Abt-925"],"linkedTargets":{"rows":["ENSG00000151577"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL45844","canonicalSmiles":"O=CN(C1CCCC1)C1CCC1","inchiKey":"DWGVYBRKKSJLNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBUTYL(CYCLOPENTYL)FORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04065"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459324","canonicalSmiles":"CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"GVGLGOZIDCSQPN-PVHGPHFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIACETYLMORPHINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diacetylmorphine","IDS-NH-001","IDS-NH-001(SECT.3)","J6.494G"],"crossReferences":{"PubChem":["144206165"],"Wikipedia":["Heroin"],"drugbank":["DB01452"],"chEBI":["27808"]},"childChemblIds":["CHEMBL2106627"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0004240","EFO_0003890","Orphanet_232","EFO_0005611","EFO_0010702","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for drug dependence and has 2 investigational indications."}
{"id":"CHEMBL4594316","drugType":"Antibody","blackBoxWarning":false,"name":"CROVALIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crovalimab","RG-6107","RG6107","RO-7112689","RO7112689","Ro7112689","SKY-59","SKY59"],"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["Orphanet_2134","Orphanet_232","Orphanet_447"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594420","canonicalSmiles":"Cc1c[nH]c(-c2ccc(-c3ccc(NC(=O)Nc4c(F)cc(F)cc4F)cc3F)c3c2C(=O)NC3)n1","inchiKey":"MWHHJYUHCZWSLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUXEPTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG'806","CG-026806","CG-806","CG026806","CG806","Cg-806","Luxeptinib"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594586","drugType":"Unknown","blackBoxWarning":false,"name":"PGT-121","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PGT-121","PGT121","Pgt-121","Pgt121"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460102","canonicalSmiles":"Cc1ncc(-c2nc(Nc3ccc(C(=O)N4CC[C@H](N(C)C)C4)cc3)ncc2F)n1C(C)C","inchiKey":"BACSZMCLZIDTIO-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460102","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650272","canonicalSmiles":"CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1.Cl.Cl","inchiKey":"BRCYOXKEDFAUSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRILACICLIB DIHYDROCHLORIDE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3894860","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cosela"],"synonyms":["Trilaciclib dihydrochloride"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0000702","EFO_0007053"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for small cell lung carcinoma."}
{"id":"CHEMBL4650376","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"AUTOGENE CEVUMERAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Autogene cevumeran","RO-7198457","RO7198457","Ro7198457"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4802222","drugType":"Unknown","blackBoxWarning":false,"name":"OSTABOLIN-C","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ostabolin-c","PTH-1-31 CYCLIC","ZT-031","Zt-031"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL504760","canonicalSmiles":"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2","inchiKey":"DSSYKIVIOFKYAU-XCBNKYQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMPHOR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Camphor","Camphor (natural)","Camphor (synthetic)","Camphor d-form","Camphor laurel","Camphor laurel whole","Camphor tree whole","Camphor whole","Camphor, d-","Camphor, dl-","Camphor, racemic","Camphora","Camphora camphora","Camphora officinalis whole","Camphora tree","Camphortree whole","Camphorwood","Cinnamomum camphora","Cinnamomum camphora whole","Cinnamonum camphora","D-camphor","Dextrocamphor","Dl-camphor","FEMA NO. 2230","FEMA NO. 4513","Gum camphor","Karpura whole","Laurus camphora","NSC-755918","Natural camphor","Synthetic camphor","Trans-pi-oxocamphor"],"crossReferences":{"PubChem":["144204546","144209385","144213369","170465497","17389023","17389071","26752736","29215100","49816688","50105387"],"drugbank":["DB01744"],"chEBI":["15396"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 12 approved indications."}
{"id":"CHEMBL51","canonicalSmiles":"O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1","inchiKey":"FPCCSQOGAWCVBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETANSERIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sufrexal"],"synonyms":["KJK 945","Ketanserin","Ketanserin tartrate","NSC-758959","Perketan","R 49945","R-41,468","R-41468","R-49945","Serepress"],"crossReferences":{"PubChem":["104171396","11113781","144204416","170466645","26747132","26747133","26751962","26755333","50103875","50104634","90340810"],"Wikipedia":["Ketanserin"],"drugbank":["DB12465"],"chEBI":["6123"]},"childChemblIds":["CHEMBL2062337","CHEMBL1724541","CHEMBL1628637","CHEMBL1256709","CHEMBL4303471"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL515606","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O","inchiKey":"HHHKFGXWKKUNCY-FHWLQOOXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILAZAPRIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inhibace","Vascace"],"synonyms":["Anhydrous cilazapril","Cilazapril","Cilazapril anhydrous","Cilazapril hydrate","Cilazapril monohydrate","Cilazaprilum","Initiss","Justor","RO 31-2848/006","RO-312848006"],"crossReferences":{"PubChem":["144206524"],"Wikipedia":["Cilazapril"],"drugbank":["DB01340"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL522387","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1","inchiKey":"HJWMLCDGRWWLAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522387","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06882"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL525239","canonicalSmiles":"C/C(=C\\CNc1ncnc2[nH]cnc12)CO","inchiKey":"UZKQTCBAMSWPJD-FARCUNLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trans-Zeatin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trans-Zeatin"],"crossReferences":{"PubChem":["11113291","26754340","47193867"],"drugbank":["DB11337"],"chEBI":["16522"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559638","canonicalSmiles":"O=C1c2cccc3c(NCCO)ccc(c23)C(=O)N1c1cccc(Br)c1","inchiKey":"JZCUVYNOSDWORZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL559638","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566315","canonicalSmiles":"CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O","inchiKey":"ZXERDUOLZKYMJM-ZWECCWDJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OBETICHOLIC ACID","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ocaliva"],"synonyms":["6-ecdca","6-ethylchenodeoxycholic acid","DSP-1747","INT-747","Obeticholic acid"],"crossReferences":{"DailyMed":["obeticholic%20acid"],"drugbank":["DB05990"]},"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_0000280","HP_0000989","MONDO_0001751","EFO_0003095","HP_0002024","HP_0002014","EFO_0004267","EFO_1001249","EFO_1001345","EFO_1001486","EFO_0001073","HP_0030151","Orphanet_98306","EFO_0004268","Orphanet_733","EFO_0001421"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL588046","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.Cl","inchiKey":"LBSFSRMTJJPTCW-DSXUQNDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUININE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anhydrous quinine hydrochloride","Chininum muriaticum","FEMA NO. 2976","FEMA NO. 2976, DIHYDRATE-","Quinine hcl","Quinine hydrochloride","Quinine hydrochloride anhydrous","Quinine hydrochloride dihydrate","Quinine hydrochloride hydrate","Quinine monohydrochloride","Quinine muriate","Quinini hydrochloridum"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL64579","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cccc(OC4CCCC4)c3O)cc2c1","inchiKey":"CFSQPEBVGUSQII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL64579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03173"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL70046","canonicalSmiles":"O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C/Br","inchiKey":"GCQYYIHYQMVWLT-HQNLTJAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORIVUDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Japan"],"year":1993},"tradeNames":["Bravavir"],"synonyms":["Brovavir","Bv-arau","SO 32,756","SO-32756","SQ 32,756","SQ-32756","Sorivudine","YN-72"],"crossReferences":{"drugbank":["DB11998"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications. It was withdrawn in Japan  in 1993."}
{"id":"CHEMBL711","canonicalSmiles":"O=C1c2ccccc2C(=O)C1c1ccccc1","inchiKey":"NFBAXHOPROOJAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENINDIONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dindevan","Hedulin"],"synonyms":["Danilone","NSC-41693","Phenindione","Phenylindanedione"],"crossReferences":{"PubChem":["11112218","11532881","144203926","170465130","26748198","26748199","50107356","50107357","56423141"],"Wikipedia":["Phenindione"],"drugbank":["DB00498"],"chEBI":["8066"]},"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["HP_0004419","EFO_0002950"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for recurrent thrombophlebitis and has 1 investigational indication."}
{"id":"CHEMBL7390","canonicalSmiles":"COc1ccc(S(=O)(=O)N2CN(Cc3ccccc3)C(=O)C[C@@H]2C(=O)NO)cc1","inchiKey":"SUSMVCKSLVPRCL-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL7390","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04140"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL85","canonicalSmiles":"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2","inchiKey":"RAPZEAPATHNIPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RISPERIDONE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Perseris kit","Risperdal","Risperdal Consta Long Acting","Risperdal M","Risperdal M-Tab","Risperdal consta","Risperdal quicklet","Risperidone"],"synonyms":["LY-03004","LY03004","N05AX08","NSC-759895","Perseris","R 64 766","R-64,766","R-64-766","R-64766","RCN-3028","RCN3028","Risperidone"],"crossReferences":{"DailyMed":["risperidone"],"PubChem":["104171228","11111724","11111725","124881313","124881314","144203804","170464925","26719830","26753640","49666400","50106974","50106975","50123965","85231208"],"Wikipedia":["Risperidone"],"drugbank":["DB00734"],"chEBI":["8871"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0004938","MONDO_0005090","EFO_0002610","EFO_0004718","EFO_0004280","EFO_0004216","MONDO_0002009","HP_0000726","EFO_0003015","EFO_0003847","EFO_0003757","EFO_0009267","Orphanet_778","EFO_0010642","MONDO_0002046","EFO_0000289","MONDO_0002050","EFO_0003761","EFO_0009854","EFO_0004701","EFO_0005230","EFO_0004215","EFO_0003888","EFO_0003756","HP_0010865","HP_0012076","MONDO_0001087","EFO_0000677","EFO_0003758","EFO_1000904","EFO_0009963","EFO_0005407","EFO_0001358","EFO_0003852","HP_0000713","Orphanet_399","EFO_0003890","MONDO_0002491","Orphanet_79292","EFO_0004895","MONDO_0004975","EFO_0005611","EFO_0005411"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 7 approved and 25 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL915","canonicalSmiles":"CCCc1c2oc(C(=O)[O-])cc(=O)c2cc2c(=O)cc(C(=O)[O-])n(CC)c12.[Na+].[Na+]","inchiKey":"JQEKDNLKIVGXAU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"NEDOCROMIL SODIUM","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL746","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alocril","Nedocromil sodium","Rapitil","Tilade","Tilarin"],"synonyms":["FPL 59002KP","FPL-59002KP","Nedocromil disodium salt","Nedocromil sodium","Tayled"],"crossReferences":{"DailyMed":["nedocromil%20sodium"],"chEBI":["7493"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for allergic conjunctivitis."}
